CT SCAN HAS PROMISING DEVELOPMENT ON LUNG CANCER

Reading time is 1 mins

.
.
PROMISING DEVELOPMENT ON LUNG CANCER

  • British scientists have shared the promising results of pre-computed Tomography (CT) in terms of early detection for people at risk of developing lung cancer.
    .
  • In the UK, scientists have asked the British government to routinely scan smokers with a CT scan (CT) to reduce deaths from lung cancer.
    .
  • According to the Guardian, about 48 thousand people in the country are diagnosed with lung cancer every year, and more than 35 thousand people lose their lives. Lung cancer, which is difficult to detect, is usually diagnosed in the third or fourth stage.

.
A REALLY BIG IMPROVEMENT

  • New methods developed in computed tomography show promise in early detection of lung cancer, according to a study conducted by scientists.
    .
  • Computed tomography detects 70 percent of the cancerous cells detected in people’s lungs in the first or second stage.
    .
  • A doctor involved in the research “This is really a big improvement for lung cancer, it allows us to detect this deadly cancer early and offer the patient curative treatment,” and went on to say:
    .
    “It is important to highlight how effective computed tomography scanning is. In my lung cancer clinic, 7 out of every 10 people are in an incurable condition after seeing a doctor,” was said.

.
RESEARCH INVOLVING 12,100 PEOPLE

  • A study of 12,100 people in London aged between 55 and 78 who smoked found 180 cases of lung cancer using CT scans.
    .
  • 70 percent of people who had cancer were told they were in the first and second stages. Following the research, experts called for the government to launch routine screening to reduce the death toll from cancer.
    .
  • The study also found that the proportion of cases detected in the first or second stage was 19.5 percent in 2013, rising to 29 percent in 2019.
    .
    .
    .
Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.

Awards:

Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.

Certificates:

Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.

Disclaimer:

Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me
Latest posts by Medically Reviewed by Professor Doctor Alper Demirbaş (see all)